Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has scheduled an earnings conference call for investors and analysts on Wednesday, January 28, 2026, at 6:30 PM IST, lasting 60 minutes. The management will discuss the company's financial performance and business updates for the quarter and nine months ended December 31, 2025 (Q3 FY26). The call will also include a Q&A session. Dial-in numbers have been shared for participants in India, the USA, the UK, Singapore, and Hong Kong. The audio recording and transcript will be uploaded to the company's website after the call.
This is a routine announcement ahead of the Q3 FY26 results, signaling that the earnings release is forthcoming on or around January 28, 2026. Investors should watch for management commentary on revenue growth, margins, and business outlook, which could influence short-term stock sentiment.